ArticleLeukemia2025
Erythroid-predominant myelodysplastic neoplasms exhibit a distinct genomic landscape with poor outcomes after venetoclax-based therapy.
Alexandre Bazinet et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this paperpooled itcites it